| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Ann Thorac Surg 2006;82:417-423
© 2006 The Society of Thoracic Surgeons
a Department of Surgery, Emory University, Atlanta, Georgia
b Division of Cardiothoracic Surgery, University of Alabama at Birmingham, Birmingham, Alabama
c Division of Cardiothoracic Surgery, Department of Surgery, Birmingham Veterans Administration Hospital, Birmingham, Alabama
d Department of Pathology, Birmingham, Alabama
e Division of Nuclear Radiology, University of Alabama at Birmingham Hospital, Birmingham, Alabama
Accepted for publication December 13, 2005.
* Address correspondence to Dr Bryant, Division of Cardiothoracic Surgery, University of Alabama at Birmingham, 1900 University Blvd., THT 712, Birmingham, AL 35294 (Email: abryant{at}uab.edu).
Presented at the Fifty-second Annual Meeting of the Southern Thoracic Surgical Association, Orlando, FL, Nov 10–12, 2005.
BACKGROUND: Positron emission tomography (PET) scans often help direct biopsies of mediastinal lymph nodes in patients with non-small cell lung cancer (NSCLC), but the maximum standard uptake value (maxSUV) of individual nodes has not been evaluated.
METHODS: This is a prospective study of consecutive patients with NSCLC, all of whom underwent integrated fluorodeoxyglucose-positron emission-computed tomography (FDG-PET-CT) and had biopsy or resection of their mediastinal lymph nodes.
RESULTS: There were 397 patients. One-hundred and forty-three patients had N2 disease and 1,252 N2 nodes were pathologically examined. The median maxSUV of the nodes that had metastatic disease were the following: for the 2R node, 10.4 (range, 0–18.6); for 4R, 8.6 (range, 0–18.3); for 5, 8.9 (range, 0–26.3); for 6, 7.6 (range, 0–19.6); for 7, 7.7 (range, 0–14); for 8 and 9, 5.4 (range, 0–8.9). The median maxSUV for all of the N2 nodes that were benign was 0 (range, 0–18.8) (p < 0.05 for all stations except for nodes 8 and 9). When a maxSUV of 5.3 is used the accuracy of integrated FDG-PET-CT for each N2 nodal station is maximized and is at least 92% for each.
CONCLUSIONS: The maxSUV of individual mediastinal lymph nodes is a predictor of malignancy. There is overlap between false and true positives. Definitive biopsies are required to prove cancer irrespective of the maxSUV value. However, when a maxSUV of 5.3 is used instead of the traditional value of 2.5, the accuracy for FDG-PET-CT for each N2 nodal station increases to at least 92%.
This article has been cited by other articles:
|
|
 |
|
  B. E. Lee, J. Redwine, C. Foster, E. Abella, T. Lown, D. Lau, and D. Follette Mediastinoscopy might not be necessary in patients with non-small cell lung cancer with mediastinal lymph nodes having a maximum standardized uptake value of less than 5.3 J. Thorac. Cardiovasc. Surg., March 1, 2008; 135(3): 615 - 619. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. D. Soyka, P. Veit-Haibach, K. Strobel, S. Breitenstein, A. Tschopp, K. A. Mende, M. P. Lago, and T. F. Hany Staging Pathways in Recurrent Colorectal Carcinoma: Is Contrast-Enhanced 18F-FDG PET/CT the Diagnostic Tool of Choice? J. Nucl. Med., March 1, 2008; 49(3): 354 - 361. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Leschber, D. Sperling, W. Klemm, and J. Merk Does video-mediastinoscopy improve the results of conventional mediastinoscopy? Eur. J. Cardiothorac. Surg., February 1, 2008; 33(2): 289 - 293. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. J. Cerfolio and A. S. Bryant Reply Ann. Thorac. Surg., November 1, 2007; 84(5): 1798 - 1798. [Full Text] [PDF]
|
|
|
|
|
|
J. L. Fleckenstein Maximum Standard Uptake Values of Mediastinal Nodes on PET and CT Ann. Thorac. Surg., November 1, 2007; 84(5): 1797 - 1798. [Full Text] [PDF]
|
|
|
|
|
|
D. Hellwig, T. P. Graeter, D. Ukena, A. Groeschel, G. W. Sybrecht, H.-J. Schaefers, and C.-M. Kirsch 18F-FDG PET for Mediastinal Staging of Lung Cancer: Which SUV Threshold Makes Sense? J. Nucl. Med., November 1, 2007; 48(11): 1761 - 1766. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. J. Cerfolio and A. S. Bryant When is it Best to Repeat a 2-Fluoro-2-Deoxy-D-Glucose Positron Emission Tomography/Computed Tomography Scan on Patients with Non-Small Cell Lung Cancer Who Have Received Neoadjuvant Chemoradiotherapy? Ann. Thorac. Surg., October 1, 2007; 84(4): 1092 - 1097. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. C Detterbeck Evolution and science, progress and change Thorax, August 1, 2007; 62(8): 654 - 655. [Full Text] [PDF]
|
|
|
|
|
|
R. J. Cerfolio and A. S. Bryant Predictors of Survival and Disease-Free Survival in Patients With Resected N1 Non-Small Cell Lung Cancer Ann. Thorac. Surg., July 1, 2007; 84(1): 182 - 190. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. J. Cerfolio and A. S. Bryant Ratio of the Maximum Standardized Uptake Value on FDG-PET of the Mediastinal (N2) Lymph Nodes to the Primary Tumor May Be a Universal Predictor of Nodal Malignancy in Patients With Nonsmall-Cell Lung Cancer Ann. Thorac. Surg., May 1, 2007; 83(5): 1826 - 1830. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. S. Bryant and R. J. Cerfolio The clinical stage of non-small cell lung cancer as assessed by means of fluorodeoxyglucose-positron emission tomographic/computed tomographic scanning is less accurate in cigarette smokers J. Thorac. Cardiovasc. Surg., December 1, 2006; 132(6): 1363 - 1368. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. S. Bryant and R. J. Cerfolio The maximum standardized uptake values on integrated FDG-PET/CT is useful in differentiating benign from malignant pulmonary nodules. Ann. Thorac. Surg., September 1, 2006; 82(3): 1016 - 1020. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |
